196 related articles for article (PubMed ID: 11598362)
21. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
Nakashima A; Kobayashi T; Terao T
Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
[TBL] [Abstract][Full Text] [Related]
22. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
[TBL] [Abstract][Full Text] [Related]
24. [Changes in fibrinolysis-associated parameters in HELLP syndrome].
Kolben M; Lopens A; Schmitt M; Schneider KT; Graeff H
Geburtshilfe Frauenheilkd; 1994 May; 54(5):257-61. PubMed ID: 8050684
[TBL] [Abstract][Full Text] [Related]
25. The imbalance of plasminogen activators and inhibitor in preeclampsia.
Gao M; Nakabayashi M; Sakura M; Takeda Y
J Obstet Gynaecol Res; 1996 Feb; 22(1):9-16. PubMed ID: 8624901
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
27. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
Koh SC; Anandakumar C; Biswas A; Fong YF
Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
[No Abstract] [Full Text] [Related]
28. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
29. The fibrinolytic system in human ascites.
Buø L; Karlsrud TS; Dyrhaug G; Bell H; Engström L; Johansen HT; Aasen AO
Scand J Gastroenterol; 1995 Nov; 30(11):1101-7. PubMed ID: 8578171
[TBL] [Abstract][Full Text] [Related]
30. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
31. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
[TBL] [Abstract][Full Text] [Related]
33. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
35. Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.
Estellés A; Grancha S; Gilabert J; Thinnes T; Chirivella M; España F; Aznar J; Loskutoff DJ
Am J Pathol; 1996 Oct; 149(4):1229-39. PubMed ID: 8863672
[TBL] [Abstract][Full Text] [Related]
36. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
[TBL] [Abstract][Full Text] [Related]
37. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
38. Effects of labor and delivery on fibrinolysis.
Bremer HA; Brommer EJ; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1994 Jun; 55(3):163-8. PubMed ID: 7958159
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in gastric cancer.
Ho CH; Chao Y; Lee SD; Chau WK; Wu CW; Liu SM
Thromb Res; 1998 Jul; 91(1):23-7. PubMed ID: 9700849
[TBL] [Abstract][Full Text] [Related]
40. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
